Over the past year there were no insider purchases at Alto Neuroscience, Inc.. One insider sold roughly $3.6 million instead.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
Big money check: 114 institutions held ANRO as of Q2 2026, and more funds bought than sold. Quarter by quarter: Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Smith Nicholas Conrad | CFO | Sell | 110,830 | $26.58 | $2.9M | SEC |
| Oct 1, 2026 | Smith Nicholas Conrad | CFO | Sell | 23,170 | $25.78 | $597K | SEC |
| Oct 1, 2026 | Smith Nicholas Conrad | CFO | Sell | 886 | $26.87 | $24K | SEC |
| Jul 11, 2024 | Savitz Adam | Executive Officer | Buy | 2,931 | $13.22 | $39K | SEC |
| Jul 11, 2024 | Savitz Adam | Executive Officer | Buy | 10,681 | $12.53 | $134K | SEC |
| Jul 11, 2024 | Savitz Adam | Executive Officer | Buy | 1,388 | $13.15 | $18K | SEC |
| Apr 1, 2024 | Smith Nicholas Conrad | CFO | Buy | 1,600 | $15.80 | $25K | SEC |
| Apr 1, 2024 | Smith Nicholas Conrad | CFO | Buy | 4,550 | $16.56 | $75K | SEC |
| Feb 8, 2024 | Alpha Wave Global, LP | 10% Owner | Buy | 600,000 | $16.00 | $9.6M | SEC |
| Feb 7, 2024 | Smith Nicholas Conrad | CFO | Buy | 1,563 | $16.00 | $25K | SEC |
| Feb 7, 2024 | Savitz Adam | Executive Officer | Buy | 17,000 | $16.00 | $272K | SEC |
| Feb 7, 2024 | Etkin Amit | CEO | Buy | 3,125 | $16.00 | $50K | SEC |
In the last 12 months Alto Neuroscience, Inc. insiders made open-market purchases worth about $0 and sales worth about $3.6 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ANRO was filed on 2026-10-01.
114 investment managers reported holding ANRO in SEC Form 13F filings for Q2 2026.
No congressional trades in ANRO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).